JPRN-UMIN000012171尚未招募4 期
Exploratory study of DPP-4 inhibitor on glycemic control and organ protection in type2 diabetic patients - Exploratory study of DPP-4 inhibitor on glycemic control and organ protection in type2 diabetic patients
Tokyo Jikei University School of Medicine Kashiwa Hospital0 个研究点目标入组 60 人开始时间: 2013年10月30日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 74years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Type-1 diabetes millius 2)Serum creatinin level of more than 1.2mg/dL in male patients and 1.0mg/dL in female patients 3)Diabetic ketosis, diabetic coma or total coma within 6 months 4)Severe infectious disease, before or after surgery, and severe trauma 5)Occurrence of ischemic stroke, hemorrhagic stroke or TIA within 6 months 6)Moderate or severe heart failure (NYHE 3 or 4) 7)Patients who receive other DPP4 inhibitors during 3 month before starting study 8)Under treatment with insulin 9)Pregnant, lactating, possibly pregnant or planning to become pregnant women 10)Past medical history of hypersensitivity to linagliptin 11)Patients considered as inadequate by the principal investigator
研究者
相似试验
已完成
不适用
The impact of DPP-4 inhibitor on daily glucose profile and coronary plaque character in diabetic patients with coronary artery diseasepatients with coronary artery disease and type 2 diabetesJPRN-UMIN000008344Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine44
已完成
不适用
Effect of DPP-4 inhibitor on insulin therapy for patients with type 2 diabetesType 2 diabetesJPRN-UMIN000006470Jikei University School of Medicine Kashiwa Hospital20
进行中（未招募）
不适用
ANTIDIABETIC EFFECTS OF ADDING A DPP-4 INHIBITOR (SITAGLIPTIN) TO PRE-EXISTING TREATMENT WITH AN INCRETIN MIMETIC (LIRAGLUTIDE) IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH METFORMITYPE 2 DIABETESMedDRA version: 16.0Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2013-001764-35-DEDiabeteszentrum Bad Lauterberg
已完成
3 期
Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2DType 2 DiabetesNCT01937598Michael A. Nauck16
已完成
不适用
The efficacy of DPP-4 inhibitors and alpha glucosidase inhibitors for type 2diabetesPatients with type 2 diabetesJPRN-UMIN000011788ational Center for Global Health and Medicine15